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Postpericardiotomy syndrome is a speciﬁc type of acute pericarditis because of a delayed pericardial and/
or pleural reaction after thoracic surgery. Relapse after aspirin, nonsteroidal anti-inﬂammatory drug,
and/or steroid treatment or intractable to this conventional therapy causes a troublesome situation.
Colchicine was ﬁrst proposed for treatment of recurrent pericarditis in 1987. A number of investigators
have reported the efﬁcacy and safety of colchicine in combination therapy for recurrent pericarditis.
Recently, Colchicine for Recurrent Pericarditis and Colchicine for Acute Pericarditis studies suggested that
colchicine is useful in the ﬁrst attack of acute pericarditis, and corticosteroid therapy given in the ﬁrst
attack favors the recurrence of pericarditis. In this report, we present an 82-year-old woman with severe
tricuspid regurgitation and moderate-to-severe mitral regurgitation because of rheumatic heart disease,
postpericardiotomy syndrome with severe pleural and pericardial effusion developed after the open-
heart surgery. Both pleural and pericardial effusion was intractable to steroid therapy. Colchicine and
steroid combination therapy made the syndrome remission rapidly. The total course of colchicines
therapy was 2.5 months. There was no recurrence after 1 year of clinic follow-up.
Copyright  2011, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
The postpericardiotomy syndrome (PPS) is a delayed pericardial
and/or pleural reaction following opening of the pericardium. It
manifests with fever, chest pain, and pleural or pericardial effusion,
sometimes both1,2. It may develop in approximately 30% of patients,
1e12 weeks after the surgery, no matter whether the pericardium
alone or a cardiac chamber, valve, or vessel is opened2,3. Treatments
include aspirin, nonsteroidal anti-inﬂammatory drug (NSAID), and
steroid. Recurrent episode of pericardial inﬂammation or unremit-
ting is the most troublesome situation. Colchicine is effective and
safe for treatment and prevention of the recurrence of pericarditis
especially while conventional treatment fails4e8.
In this report, we present a PPS casewho received an open-heart
surgery for mitral valve annuloplasty and tricuspid valve replace-
ment. The pericardial and pleural effusion was refractory to
conventional therapy plus pleural and pericardial drainage.
Combination therapy with colchicine and prednisolon made theInternal Medicine, Wei-Gong
aiwan. Tel.: þ886 37 676811;
).
erest.
iwan Society of Geriatric Emergenpleural and pericardial effusion cleared up rapidly. The total course
of colchicine therapy was two and half months. No recurrence was
noted after 1-year follow-up.
2. Case Report
An 82-year-old Taiwanese woman was transferred to our
hospital for refractory pleural and pericardial effusion after the
open-heart surgery. Approximately 4 months earlier, she was
admitted to our cardiologic service because of congestive heart
failure. Rheumatic heart disease with moderate-to-severe mitral
regurgitation, severe tricuspid regurgitation, and atrial ﬁbrillation
were diagnosed.
She was transferred to a medical center at Taipei after the acute
event had been controlled. Mitral valve annuloplasty and tricuspid
valve replacement with porcine valve were done 3 weeks later. The
course was smooth during surgical intervention. Sputum impaction
related respiratory failure occurred 3 days after the intervention. She
was reincubated. Steroid therapywas given. The pericardial drainage
and endotracheal tubes were removed, 21 days after that operation
when the symptoms improved. Unfortunately, right pleural effusion
developed and thoracocentesis was done the next day. The general
condition became stable and she was discharged on the 24th day
after the operation. Medications included valsartan 20 mg twicecy & Critical Care Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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furosimide 40 mg once a day were given when she was discharged.
Unfortunately, she experienced progressive shortness of breath
and was rehospitalized to that medical center again 1 week later.
Chest X-rays showed reaccumulation of right side pleural effusion.
Right chest thoracostomy with pig-tail drainage was done the next
day. Dyspnea and orthopnea were improved. She was discharged
on the eighth day of the second hospitalization after the pig-tail
was removed.
Approximately 1 week after the second discharge, she noted
dyspnea on exertion and admitted again. Right pleural effusion and
pericardial effusion were found. There was no fever or chest pain
during this period. Because of intolerance to aspirin and NSAID,
steroid was only given. Because of poor response to medical
treatment, pig-tail drainage for plural effusion and pericardial
drainage with chest tube was done on 25th and 28th days, respec-
tively after she was readmitted. Yellowish, clear, transudatory ﬂuid
was drained from both pleural and pericardial cavities. Pericardial
biopsy revealed pericardial soft tissue with ﬁbrosis histologically.
Refractory pericardial effusion persisted with daily drainage around
300 mL. She was transferred to our hospital on the 45th day after
this admission.
On admission, the patient appeared thin (body weight: 49.5 kg
and body mass index: 19.5 kg/m2) and had dyspnea on exertion.
Cardiovascular system examination disclosed irregularly irregular
heart beat with rate about 100/min, a Grade I/VI systolic murmur
along lower left sternal border was noted. Extremities had no
edema. The right-sided pleural and pericardial drainage tubes were
in places and straw color ﬂuid was drained out. The 12-lead elec-
trocardiogram disclosed atrial ﬁbrillation with ventricular rate at
100/min, incomplete right bundle branch block, and right ventric-
ular hypertrophy. The chest ﬁlm showed cardiomegaly and tortu-
osity of the aorta with curvilinear calciﬁcation at aortic arch,
engorgement of pulmonary vascularity over bilateral parahilar
regions, right side pleural effusion with pig-tail in right costo-
phrenic angle and a mediastinal drainage tube in place, and
retention surgical wires in the chest wall.
The transthoracic echocardiogram demonstrated trivial mitral
regurgitation and porcine valve replacement of tricuspid valve with
trivial tricuspid regurgitation, thickening and calciﬁcation of aortic
valve with mild aortic regurgitation, minimal pericardial, and right
pleural effusion; and LV ejection fraction was 50.5%.
The daily drainage of pleural effusion and pericardial effusion
were 5e10 mL and 200e300 mL, respectively. Cytology study of
pericardial and pleural ﬂuid was negative for malignancy, andFig. 1. (A and B) Chest ﬁlm showing decreased pleural effusion 1 week after combination th
1 year later.pericardial ﬂuid contained reactive mesothelial cells and lympho-
cytes in the pericardial ﬂuid. Prednisolone 30 mg/d combined with
colchicinewas given on the eighth hospital day. The amount of ﬂuid
drainage from right pleural and pericardial cavity began to decrease
3 days after this regime (Fig. 1). The pig-tail tube for right pleural
drainage was removed on 30th day.
Finally, the pericardial drainage was pulled out 2 weeks later.
She was discharged with colchicine and prednisolone, 0.5 mg and
5 mg per day, respectively on the 37th day. The dosage of prednis-
olone was tapered down in 1 week and colchicine was given for
another 2 weeks. The total course of colchicine therapy was about
two and half months. There is no evidence of recurrence of peri-
cardial and pleural effusion in 1 year of clinic follow-up (Fig. 1).
3. Discussion
Colchicine was ﬁrst proposed for the treatment of recurrent
pericarditis in 1987 by Rorigue de la Serna et al4 based on its proven
efﬁcacy to prevent relapses of polyserositis in familial Mediterra-
nean fever. Three years later, in 1990, Guindo et al5 published the
ﬁrst clinical study supporting the efﬁcacy of cochicine in preventing
recurrence of pericarditis. Recently, the Colchicine for Recurrent
Pericarditis (CORE) trial stated that colchicine therapy led to a clin-
ically important and statistically signiﬁcant beneﬁt over conven-
tional treatment, decreasing the recurrence rate in patients with
a ﬁrst episode of recurrent pericarditis6. In this study, 48 consecu-
tive patients with ﬁrst episode of recurrent pericarditis were
randomly assigned to receive conventional treatment with aspirin
alone, or conventional treatment plus colchicine (1.0e2.0 mg the
ﬁrst day and then 0.5e1.0 mg/d for 6 months). When aspirin was
contraindicated, prednisolone (1.0e1.5 mg/kg daily) was given for 1
month and then gradually tapered. During 1,682 patient-month,
treatment with colchicine signiﬁcantly decreased the recurrence
rate (actuarial rate at 18 months were 24% vs. 50.6%; p¼ 0.02) and
the symptom persistence at 72 hours (10% vs. 31%; p¼ 0.03).
Another clinical study, the Colchicine for Acute Pericarditis
(COPE) trial provides evidence that colchicine in combination
therapy with aspirin or prednisolone is safe and effective in the
treatment of the ﬁrst episode of acute pericarditis and decreasing
the recurrence rate7,8. In this study, a total of 120 patients with
a ﬁrst episode of acute pericarditis (idiopathic, viral, PPS, and
connective tissue diseases) were randomly assigned to conven-
tional treatment with aspirin or conventional treatment plus
colchicine 1.0e2.0 mg for the ﬁrst day and then 0.5e1.0 mg/d for
3 months. Corticosteroid therapy was restricted to patient witherapy of colchicine and prednisolone. (C) No recurrent pleural and pericardial effusion
L.-S. Li et al122aspirin contraindication or intolerance. The addition of colchicine
reduced the recurrent rate at 18 months from 32.3% to 10.7%.
Persistence of symptoms at 72 hours after the onset of acute peri-
carditis was also signiﬁcantly reduced by two-thirds in colchicine
treatment group. Both CORE and COPE data conﬁrmed that the
prior corticosteroid use remained an independent risk factor for the
development of recurrent pericarditis6e8.
In this report, in our case treated by combination therapy of
colchicine and prednisone, the pericardial effusion cleared up
about in 1 month after this therapy. The total course of colchicine
therapy was two and half months. No recurrent was noted 1 year
later. Here, in Taiwan, Chien and Shen9 report a case of chronic PPS
with cardiac tamponade last for 2 years after an open-heart
surgery. The patient was treated successfully with thorcoscopic
partial pericardiectomy. But low-dose maintenance steroid and
colchicine were also given for 2 months. In the series of patient
studies for an average of 10 years by Fowler and Harbin, nine had
undergone pericardiectomy but clear improvement resulted in only
two patients8. This unsatisfactory outcome differed from an earlier
enthusiastic recommendation that recurrent pericarditis should be
treated by pericardiectomy8,10.
In summary, the PPS is a speciﬁc type of acute pericarditis
because of delayed pericardial and/or pleural reaction after peri-
cardial opening. In the last decade, many enthusiastic reports
conﬁrmed the efﬁcacy of colchicine as adjuvant treatment of acute
pericarditis. Recently, CORE and COPE studies reconﬁrmed the
efﬁcacy of colchicines in preventing relapse.
In addition, these studies give us other two messages: ﬁrst,
colchicine should be considered as the ﬁrst-line treatment for acute
pericarditis and for preventing recurrent episodes. Second, corti-
costeroid therapy is a risk factor for development of relapse inpericarditis11,12. Accordingly, it was recommended that steroids not
be used for initial treatment of pericarditis or recurrences, unless
the patient has no response to NSAID or colchicine or if these drugs
are both contraindicated12.References
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